The PARP Inhibitors Market Size is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 15.5 Billion by the year 2034 at a 15.2% CAGR during the forecast period for 2025-2034. Poly (ADP-ribose) polymerase (PARP) inhibitors represent a class of targeted […]
Read More>>